Bought
Maintained
Sold
Other funds holding MRK
Swiss Re's MRK Position: Q3 2026 in Review
Swiss Re increased its Merck (MRK) stake by 65% in Q3 2026, buying an estimated $540K and bringing the position to 9,969 shares worth $1.45M. The position accounts for 0.76% of the portfolio, ranked #23.
Swiss Re first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Swiss Re held 9,969 shares of Merck worth $1.45M as of Q3 2026.
- Swiss Re bought 3,911 Merck shares in Q3 2026, an estimated $540K.
- Merck made up 0.76% of Swiss Re's portfolio in Q3 2026, its #23 holding.
- Swiss Re first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
- 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Swiss Re's 13F filing for Q3 2026, filed 6 Nov 2026.